Back
Phathom Pharmaceuticals Quote, Financials, Valuation and Earnings
The Mysterious VC Firm Behind Nvidia's Secret Weapon
Details Here!
Sell
32
PHAT
Phathom Pharmaceuticals
Last Price:
9.55
Seasonality Move:
-9.75%
7 Day Trial
ALL ACCESS PASS
$
7
Trump's IRS Hands Massive 'Victory Gift' To 401K Owners
Shield your IRA, 401(k) and pension savings from this coming anti-Trump backlash.Phathom Pharmaceuticals Price Quote
$9.55
-3.49 (-26.76%)
(Updated: November 12, 2024 at 5:55 PM ET)
Phathom Pharmaceuticals Key Stats
Sell
32
Phathom Pharmaceuticals (PHAT)
is a Sell
Day range:
$12.95 - $17.63
52-week range:
$6.07 - $19.71
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
29.65
P/B ratio:
0%
Volume:
4.5M
Avg. volume:
1.1M
1-year change:
73.64%
Market cap:
$891.6M
Revenue:
$682K
EPS:
$-5.75
How Much Does Phathom Pharmaceuticals Make?
-
How Much Are Phathom Pharmaceuticals's Sales Annually?
PHAT Revenues are $682K -
How Much Profit Does Phathom Pharmaceuticals's Make A Year?
PHAT net income is -$201.6M
Is Phathom Pharmaceuticals Growing As A Company?
Data Unavailable
Phathom Pharmaceuticals Stock Price Performance
-
Did Phathom Pharmaceuticals Stock Go Up Last Month?
Phathom Pharmaceuticals share price went down by -13.59% last month -
Did PHAT's Share Price Rise Over The Last Year?
PHAT share price rose by 73.64% over the past 1 year
What Is Phathom Pharmaceuticals 52-Week High & Low?
-
What Is Phathom Pharmaceuticals’s 52-Week High Share Price?
Phathom Pharmaceuticals has traded as high as $19.71 over the past 52 weeks -
What Is Phathom Pharmaceuticals’s 52-Week Low Share Price?
Phathom Pharmaceuticals has traded as low as $6.07 over the past 52 weeks
Phathom Pharmaceuticals Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Phathom Pharmaceuticals?
-
How Much Debt Does Phathom Pharmaceuticals Have?
Total long term debt quarterly is $175.7M -
How Much Cash Does Phathom Pharmaceuticals Have?
Cash and short term investments quarterly total is $334.7M -
What Is Phathom Pharmaceuticals’s Book Value Per Share?
Book value per share is -2.74
Is Phathom Pharmaceuticals Cash Flow Positive?
-
What Is PHAT Cash Flow From Operations?
Cash flow from operations (TTM) is -$247.1M -
What Is Phathom Pharmaceuticals’s Cash Flow From Financing?
Cash flow from financing (TTM) is $368.7M -
What Is Phathom Pharmaceuticals’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$605K
Phathom Pharmaceuticals Return On Invested Capital
Data Unavailable
Phathom Pharmaceuticals Earnings Date & Stock Price
-
What Is Phathom Pharmaceuticals's Stock Price Today?
A single share of PHAT can be purchased today for 13.04 -
What Is Phathom Pharmaceuticals’s Stock Symbol?
Phathom Pharmaceuticals trades on the nasdaq under the ticker symbol: PHAT -
When Is Phathom Pharmaceuticals’s Next Earnings Date?
The next quarterly earnings date for Phathom Pharmaceuticals is scheduled on March 7, 2025 -
When Is PHAT's next ex-dividend date?
Phathom Pharmaceuticals's next ex-dividend date is May 26, 2020 -
How To Buy Phathom Pharmaceuticals Stock?
You can buy Phathom Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Phathom Pharmaceuticals Competitors
-
Who Are Phathom Pharmaceuticals's Competitors?
Below is a list of companies who compete with Phathom Pharmaceuticals or are related in some way:
Phathom Pharmaceuticals Dividend Yield
-
What Is PHAT Dividend Yield?
Phathom Pharmaceuticals’s dividend yield currently is 0% -
What Is Phathom Pharmaceuticals’s Payout Ratio?
Phathom Pharmaceuticals’s payout ratio is 0% -
When Did Phathom Pharmaceuticals Last Pay A Dividend?
The latest dividend pay date is November 12, 2024 -
What Is Phathom Pharmaceuticals’s Dividend Per Share?
Phathom Pharmaceuticals pays a dividend of $0.00 per share
Phathom Pharmaceuticals Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | 28.33% |
| Revenue: | 0% | 31.73% |
Analyst Recommendations
| Buy Recommendations: | 4 |
|---|---|
| Hold Recommendations: | 1 |
| Sell Recommendations: | 0 |
| Price Target: | 25.29 |
| Upside from Last Price: | 93.91% |